NASDAQ:ALQA - Alliqua Biomedical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.30 +0.07 (+3.14 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$2.30
Today's Range$2.24 - $2.30
52-Week Range$1.55 - $5.24
Volume83,665 shs
Average Volume332,108 shs
Market Capitalization$11.51 million
P/E Ratio-0.35
Dividend YieldN/A
Beta1.62
Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. The company markets MIST Ultrasound Healing Therapy, a painless noncontact low-frequency ultrasound to promote healing; and Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix, which are human biologic regenerative technologies. It also provides contract manufacturing services, including the development, manufacture, and marketing of high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Yardley, Pennsylvania.

Receive ALQA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALQA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALQA
CUSIPN/A
Phone215-702-8550

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.57 million
Book Value$3.14 per share

Profitability

Net Income$-25,700,000.00

Miscellaneous

Employees60
Market Cap$11.51 million
OptionableNot Optionable

Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions

What is Alliqua Biomedical's stock symbol?

Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA."

When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work?

Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split.

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) issued its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of ($2.70) by $3.20. The firm had revenue of $5.50 million for the quarter, compared to analyst estimates of $5.38 million. Alliqua Biomedical had a negative net margin of 90.46% and a negative return on equity of 235.73%. View Alliqua Biomedical's Earnings History.

When is Alliqua Biomedical's next earnings date?

Alliqua Biomedical is scheduled to release their next quarterly earnings announcement on Friday, March 1st 2019. View Earnings Estimates for Alliqua Biomedical.

Has Alliqua Biomedical been receiving favorable news coverage?

Headlines about ALQA stock have been trending somewhat negative on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Alliqua Biomedical earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term.

Who are some of Alliqua Biomedical's key competitors?

Who are Alliqua Biomedical's key executives?

Alliqua Biomedical's management team includes the folowing people:
  • Mr. David Ian Johnson, Pres, CEO & Director (Age 61)
  • Mr. Joseph M. Warusz, CFO, Treasurer & Sec. (Age 63)
  • Dr. Phillip D. Forman M.D., DPM, Exec. VP of Clinical Affairs (Age 60)
  • Mr. Gregory Robb, VP of Operations

Who are Alliqua Biomedical's major shareholders?

Alliqua Biomedical's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Virtu Financial LLC (0.51%). Company insiders that own Alliqua Biomedical stock include Bradford Barton, Corp /De/ Celgene, David Ian Johnson, Jerome B Zeldis and Mark T Wagner. View Institutional Ownership Trends for Alliqua Biomedical.

Which major investors are buying Alliqua Biomedical stock?

ALQA stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC. Company insiders that have bought Alliqua Biomedical stock in the last two years include Bradford Barton, Corp /De/ Celgene, David Ian Johnson, Jerome B Zeldis and Mark T Wagner. View Insider Buying and Selling for Alliqua Biomedical.

How do I buy shares of Alliqua Biomedical?

Shares of ALQA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alliqua Biomedical's stock price today?

One share of ALQA stock can currently be purchased for approximately $2.30.

How big of a company is Alliqua Biomedical?

Alliqua Biomedical has a market capitalization of $11.51 million and generates $19.57 million in revenue each year. The company earns $-25,700,000.00 in net income (profit) each year or ($6.49) on an earnings per share basis. Alliqua Biomedical employs 60 workers across the globe.

What is Alliqua Biomedical's official website?

The official website for Alliqua Biomedical is http://www.alliqua.com.

How can I contact Alliqua Biomedical?

Alliqua Biomedical's mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company can be reached via phone at 215-702-8550 or via email at [email protected]icke.com.


MarketBeat Community Rating for Alliqua Biomedical (NASDAQ ALQA)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  285 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about Alliqua Biomedical and other stocks. Vote "Outperform" if you believe ALQA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALQA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel